Browse the latest research summaries in the field of immunology for spinal cord injury patients and caregivers.
Showing 671-680 of 730 results
Journal of Neuroinflammation, 2019 • June 11, 2019
This study investigated the dose-dependent effects of intravenously administered hIgG on neuroinflammation after SCI in rats, demonstrating that hIgG (2 g/kg) is more effective than hIgG (0.4 g/kg) in...
KEY FINDING: hIgG (2 g/kg) protected the spinal cord neurovasculature after SCI by increasing tight junction protein expression and reducing inflammatory enzyme expression.
Scientific Reports, 2019 • September 6, 2019
This study investigates the potential of ECM hydrogels to deliver SCAP for reducing inflammation after spinal cord injury. The researchers evaluated the mechanical properties of bone and spinal cord d...
KEY FINDING: ECM hydrogels, particularly in solubilized form, can modulate inflammation in LPS-stimulated microglial cells, with spinal cord-derived hydrogels reducing the Nos2/Arg1 ratio and bone-derived hydrogels reducing Tnf expression.
International Journal of Molecular Sciences, 2019 • October 19, 2019
The study established an in vivo screening platform to identify modulators of zebrafish regulatory T cell (zTreg) recruitment to injured tissue. Pramipexole was found to enhance zTreg recruitment in an...
KEY FINDING: Pramipexole, a dopamine agonist, was identified as a specific enhancer of zTreg recruitment to injured tissue in zebrafish.
Exp Neurol, 2020 • January 1, 2020
This review addresses how SCI changes the physiological interplay between the spinal cord, the gut and the immune system. A suspected culprit in causing many of the pathological manifestations of impa...
KEY FINDING: SCI leads to gut dysbiosis, characterized by changes in the composition and abundance of gut bacteria, such as a decrease in Bacteroidales and an increase in Clostridiales.
Journal of Neuroinflammation, 2019 • September 23, 2019
This study investigated the therapeutic potential of tempol in SOD1G93A transgenic mice, a model for ALS. The results showed that tempol treatment enhanced neuronal survival and reduced glial cell rea...
KEY FINDING: Tempol treatment promoted greater neuronal survival (23%) at the initial stage of symptoms compared to untreated animals, and this was maintained until the end stage.
Frontiers in Immunology, 2019 • November 1, 2019
This study identifies foamy macrophages in the reactive Axolotl spinal cord meninges, revealing their participation in spinal cord regeneration. These cells accumulate in fibrotic meninges during amph...
KEY FINDING: Foam cells (foamy macrophages) accumulate in the invasive fibrotic meninges during gap regeneration of transected adult Axolotl spinal cord and may act beneficially.
J Clin Apher, 2020 • February 1, 2020
This study evaluated the efficacy and safety of IgE-selective immunoadsorption (IA) in treating severe atopic dermatitis (AD). Five patients with severe AD underwent three courses of IA, which resulte...
KEY FINDING: IgE-selective IA effectively reduced serum IgE levels in all participants by an average of 81% per cycle.
Frontiers in Immunology, 2019 • November 8, 2019
The study aimed to understand the heterogeneity among BMSC specimens and whether donor-specific variability in morphological and functional parameters could be explained by donor age and comorbidities...
KEY FINDING: BMSCs from both adult and elderly donors met standard criteria for MSCs, exhibiting similar morphology, growth kinetics, gene expression profiles, and differentiation capacity.
Nature, 2020 • January 1, 2020
This study investigates the role of adaptive immunity in Alzheimer's disease (AD) by analyzing peripheral blood and cerebrospinal fluid (CSF) samples from healthy individuals, patients with mild cogni...
KEY FINDING: Increased numbers of CD8+ TEMRA cells were found in the peripheral blood of patients with MCI or AD, and these cells were negatively associated with cognition.
Nat Neurosci, 2020 • February 1, 2020
The study identifies a novel state of microglia in the aging brain, characterized by the accumulation of lipid droplets (LDAM). LDAM exhibit a unique transcriptional signature, functional deficits in ...
KEY FINDING: Microglia in aged mouse and human brains accumulate lipid droplets, forming lipid droplet-accumulating microglia (LDAM).